Skip to main content
Clinical Trials/NCT01569230
NCT01569230UnknownNot Applicable

Clinical Trial to Evaluate and Compare the Efficacy and Safety of Individualized and Standardized Acupuncture for Knee Osteoarthritis Patients: Randomized, Single-blind, Controlled Study

Eun Jung Kim1 site in 1 country250 target enrollmentStarted: October 1, 2010Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Enrollment
250
Locations
1
Primary Endpoint
WOMAC (Western Ontario and McMaster Universities) Scale change

Study Overview

Brief Summary

The purpose of this study is to verify the efficacy and safety of acupuncture treatments (Individualized, Standardized acupuncture) for patients with knee osteoarthritis (OA).

Detailed Description

The investigators targeted the patients with knee OA. After treatment in 4 groups - individualized acupuncture treatment, standardized acupuncture treatment, sham-needle treatment, and waiting groups - the investigators will compare the effects of pain relieving and daily performing improvement. So the investigators will confirm the efficacy of acupuncture, and further the best treatment method. In addition, the investigators are going to evaluate the safety of abnormal reaction during the treatment.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Double (Participant, Outcomes Assessor)

Eligibility Criteria

Ages
20 Years to 80 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •At least 20 years of age, but below 80 years of age
  • •Knee pain from OA in one or both knees in the last 3 months or more
  • •Presence of knee OA diagnosed by an orthopedist based on American College of Rheumatology classification criteria
  • •Knee pain from OA in one or both knees rated > 4 cm on a 10 cm Visual Analog Scale (VAS)
  • •An understanding of the objectives and methods of the clinical trial, and willingness in completing the consent form.
  • •Those who are reliable and willing to cooperate in this test, and obey the restrictions for the next 3 months

Exclusion Criteria

  • •Trauma to or surgery on the knee(s) within 6 months prior to enrollment, causing pain or functional problems
  • •A history of prolotherapy, injection of hyaluronic acid or cortisone within the last 3 months
  • •A physical or laboratory finding indicating infection, presence of an autoimmune disease, or inflammatory arthritis
  • •Serious organic disease, and severe dysfunction due to the medical illness (e.g. Arrhythmia, Angina pectoris, Stroke, Asthma, etc.)
  • •More severe pain in regions other than the knee joint.
  • •When researchers evaluate that it is not appropriate to participate in this clinical test

Arms & Interventions

Individualized acupuncture

Experimental

The patients in this group received individualized acupuncture prescribed by a certified Korean Medicine Doctor with more than 6 years of oriental medicine college education and 2 years of clinical experience. The acupuncture formulas were composed based on the pattern diagnosis, which is an unique diagnosis system of Oriental Medicine.

Intervention: Individualized Acupuncture (Procedure)

Standardized Acupuncture

Experimental

The patients in this group received standardized acupuncture treatment using the same acupuncture points, applied by a certified Korean Medicine Doctor with more than 6 years of oriental medicine college education and 2 years of clinical experience. The acupuncture formulas were composed based on literature review of RCTs.

Intervention: Standardized Acupuncture (Procedure)

Sham acupuncture

Sham Comparator

Non-penetrating acupuncture device, Park-sham acupuncture, was applied to the patients. The appearance of the acupuncture is same but the needles do not penetrate the skin.

Intervention: sham acupuncture (Procedure)

Waiting

No Intervention

No interventions were applied to the patients in this group. Only assessments were made at each visit.

Intervention: Waiting (Other)

Outcomes

Primary Outcomes

WOMAC (Western Ontario and McMaster Universities) Scale change

Time Frame: at 2nd(Baseline),8(after 3weeks of treatment),13th(after 6 weeks of treatment) and 14(follow up evaluation after 6 weeks from the last treatment) visit

WOMAC scale is checked by the patients. WOMAC scale is a tool to check of the disability, stiffness and pain by knee pain.

Secondary Outcomes

  • 100mm Pain Visual Analogue Scale(at 2(Baseline), 3, 4, 5, 6, 7, 8(after 3weeks of treatment), 9, 10, 11, 12, 13(after 6 weeks of treatment), and 14th(follow up evaluation after 6 weeks from the last treatment) visit)
  • 6 Minute walk test(at 2nd(Baseline),8(after 3weeks of treatment),13th(after 6 weeks of treatment) and 14(follow up evaluation after 6 weeks from the last treatment) visit)
  • WOMAC pain(at 2(Baseline), 3, 4, 5, 6, 7, 8(after 3weeks of treatment), 9, 10, 11, 12, 13(after 6 weeks of treatment), and 14th(follow up evaluation after 6 weeks from the last treatment) visit)
  • Investigator global assessment(IGA)(at 2(Baseline), 3, 4, 5, 6, 7, 8(after 3weeks of treatment), 9, 10, 11, 12, 13(after 6 weeks of treatment), and 14th(follow up evaluation after 6 weeks from the last treatment) visit)
  • Patient global assessment(PGA)(at 2(Baseline), 3, 4, 5, 6, 7, 8(after 3weeks of treatment), 9, 10, 11, 12, 13(after 6 weeks of treatment), and 14th(follow up evaluation after 6 weeks from the last treatment) visit)
  • Adverse Events(at 2(Baseline), 3, 4, 5, 6, 7, 8(after 3weeks of treatment), 9, 10, 11, 12, 13th(end of treatment) visit)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Eun Jung Kim

Research professor

DongGuk University

Study Sites (1)

Loading locations...

Similar Trials